Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
letter
. 2020 Apr 30;67(10):1451–1453. doi: 10.1007/s12630-020-01687-4

Re-purposing a face tent as a disposable aerosol evacuation system to reduce contamination in COVID-19 patients: a simulated demonstration

Ban C H Tsui 1,
PMCID: PMC7192058  PMID: 32356164

To the Editor,

Figure.

Figure

Negative pressure tent illustration using inverted face tent (Salters Face Tent, Salter Labs, Arvin, CA, USA). Simulated aerosols were generated by an aerosol nebulizer with eight litres per minute oxygen connected to a mannequin’s airway to continuously deliver aerosolized normal saline into the mannequin’s mouth and nose. (Top) High-flow smoke evacuation system (Neptune 3, Stryker, Kalamazoo, MI, USA) was used for optimal results. The smoke evacuator contains a high efficiency particulate air filter that captures particulates as small as 0.1 µm with at least a 99.99% efficiency rate for removing harmful aerosols. (Bottom) the negative pressure tent connected to a standard suction canister from the wall inlet or anesthetic machine, which provides less suction power than higher-efficiency systems. CFM = cubic feet per minute

Prevention of severe acute respiratory syndrome coronavirus 2 infection, which causes coronavirus disease (COVID-19), has many challenges1 as the virus has been shown to survive on surfaces for up to 72 hr2 and to contaminate the surrounding environment for an extended period of time after aerosol-generating medical procedures (AGMP) such as intubation. Although effective, conventional personal protective equipment only provides a static physical barrier between the healthcare provider (HCP) and the infectious patient. Recently, a reusable “barrier enclosure” created to contain droplets from a “forceful cough” during AGMP has been widely publicized.3 As most experts recommend rapid sequence induction of anesthesia (that entails deep neuromuscular blockade) to prevent any coughing during AGMP,4 aerosolized particles remain the greater risk to HCPs when intubating COVID-19 patients rather than droplets produced by any forceful coughing. While the barrier’s ability to temporarily capture aerosolized particles has not been shown, the non-disposable barrier itself creates an additional contagious surface (fomite) for the HCP to manage and disinfect. Thus, a disposable technique to immediately evacuate all aerosols generated during AGMP may present a superior option for HCP safety.

To evacuate the generated aerosols during AGMP, a negative pressure tent (NPT) was created by re-purposing a commercially available single-use, disposable oxygen face tent (Salters face tent; Salter Labs, Arvin, CA, USA) (Figure; eVideos, available as Electronic Supplemental Material). By inverting and placing the face tent on the forehead, this tent can serve as both a physical barrier and an aerosol evacuation device. Without hindering the AGMP, this inverted face tent contains a transparent soft material with a behind-the-neck strap for a secure fit, which allows for quick adjustments. When more caudally positioned, it can act as an additional physical barrier to prevent “forceful droplets” reaching the HCP (should that remain a concern). Appropriate suction tubing can be easily adapted to connect to the face-tent inlet to draw the airflow from the patient’s face area to act as an efficient aerosol evacuation device.

To simulate the aerosols in a patient’s mouth and nose generated from the AGMP (Figure), aerosolized saline was produced (1.6 μm median diameter aerosols) using a nebulizer (Airlife Misty Max 10 disposable nebulizer; Carefusion,Yorba, CA, USA) with eight litre per minute oxygen connected to an airway mannequin’s distal bronchus to continuously deliver aerosolized vapor into the mannequin’s mouth and nose. Prior to activating suction to the NPT, the aerosols polluted the local environment. In contrast, when the NPT was placed on the forehead of the mannequin with active suction generated by a high flow smoke evacuation system (Neptune 3, Stryker, Kalamazoo, MI, USA) with 25 cubic feet per minute (CFM) or a standard suction canister from the wall inlet with 2.5 CFM, the aerosolized vapor was rapidly eliminated. After it is used, the NPT can be easily disposed of into a biohazard container to eliminate further infection risk. Most importantly, an appropriate filter such as high efficiency particulate air must be placed in the suction system to prevent virus leakage into the surrounding environment or central vacuum system. As all components of this low-cost disposable NPT are readily available, rapid implementation during intubation (and possibly extubation) procedures regardless of COVID-19 status may enhance HCP safety by actively evacuating aerosols close to their source.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Download video file (20.2MB, mp4)

Supplementary material 1 eVIDEO 1 High flow (MP4 20719 kb)

Download video file (15.5MB, mp4)

Supplementary material 2 eVIDEO 2 Standard flow (MP4 15864 kb)

Acknowledgements

The author would like to thank his pediatric anesthesiologist colleagues (Dr. Fabian Okonski, Dr. Stephanie Pan, Dr. Carole Lin and Dr. Mohammad Esfahanian), Aaron Deng (clinical research coordinator) from the Department of Anesthesiology, Lucile Packard Children’s Hospital at Stanford for their contribution.

Disclosures

None.

Funding statement

None.

Editorial responsibility

This submission was handled by Dr. Hilary P. Grocott, Editor-in-Chief, Canadian Journal of Anesthesia.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Phua J, Weng L, Ling L, et al. Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations. Lancet Respir Med. 2019 doi: 10.1016/S2213-2600(20)30161-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.van Doremalen N, Bushmaker T, Morris DH, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med. 2020 doi: 10.1056/NEJMc2004973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Canelli R, Connor CW, Gonzalez M, Nozari A, Ortega R. Barrier enclosure during endotracheal intubation. N Engl J Med. 2020 doi: 10.1056/NEJMc2007589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Cheung JC, Ho LT, Cheng JV, Cham EY, Lam KN. Staff safety during emergency airway management for COVID-19 in Hong Kong. Lancet Respir. 2020 doi: 10.1016/S2213-2600(20)30084-9. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Download video file (20.2MB, mp4)

Supplementary material 1 eVIDEO 1 High flow (MP4 20719 kb)

Download video file (15.5MB, mp4)

Supplementary material 2 eVIDEO 2 Standard flow (MP4 15864 kb)


Articles from Canadian Journal of Anaesthesia are provided here courtesy of Nature Publishing Group

RESOURCES